{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:38:45Z","timestamp":1787841525031,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12282-026-01895-8","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T07:37:05Z","timestamp":1785051425000},"page":"1173-1182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of ultrasound visibility and retrieval success of two ultrasound-visible clips in targeted axillary dissection after neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-5116","authenticated-orcid":false,"given":"Naomi","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Fukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"1895_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599\u2013609.","journal-title":"J Natl Cancer Inst"},{"key":"1895_CR2","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/annonc\/mdp016","volume":"20","author":"TS Dabakuyo","year":"2009","unstructured":"Dabakuyo TS, Fraisse J, Causeret S, Gouy S, Padeano MM, Loustalot C, et al. A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection. Ann Oncol. 2009;20:1352\u201361.","journal-title":"Ann Oncol"},{"key":"1895_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333.","journal-title":"Lancet Oncol"},{"key":"1895_CR4","doi-asserted-by":"crossref","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CMB, Gaboury Sideris L et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258\u2013\u200964.","DOI":"10.1200\/JCO.2014.55.7827"},{"key":"1895_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Scharl A, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609\u201318.","journal-title":"Lancet Oncol"},{"key":"1895_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455\u201361.","journal-title":"JAMA"},{"key":"1895_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.breast.2021.09.004","volume":"60","author":"WP Weber","year":"2021","unstructured":"Weber WP, Matrai Z, Hayoz S, Tausch C, Henke G, Zwahlen DR, et al. Tailored axillary surgery in patients with clinically node-positive breast cancer: pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23\/16, IBCSG 57-18, ABCSG-53, GBG 101). Breast. 2021;60:98\u2013110. https:\/\/doi.org\/10.1016\/j.breast.2021.09.004.","journal-title":"Breast"},{"key":"1895_CR8","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34:1072\u20138.","journal-title":"J Clin Oncol"},{"key":"1895_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","volume":"269","author":"JM Simons","year":"2019","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, Luiten EJT, Koppert LB, Smidt ML. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2019;269:432\u201342.","journal-title":"Ann Surg"},{"key":"1895_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000513037","volume":"16","author":"G Kirkilesis","year":"2021","unstructured":"Kirkilesis G, Constantinidou A, Kontos M. False negativity of targeted axillary dissection in breast cancer. Breast Care (Basel). 2021;16:532\u20138.","journal-title":"Breast Care (Basel)"},{"key":"1895_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","volume":"158","author":"S Kuemmel","year":"2023","unstructured":"Kuemmel S, Heil J, Bruzas S, Breit E, Schindowski D, Harrach H, et al. Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer. JAMA Surg. 2023;158:807\u201315.","journal-title":"JAMA Surg"},{"key":"1895_CR12","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa2414859","volume":"392","author":"EP Mamounas","year":"2025","unstructured":"Mamounas EP, Bandos H, White JR, Julian TB, Boughey JC, Kuerer HM, et al. Regional nodal irradiation in patients with node-positive breast cancer who become node-negative after neoadjuvant chemotherapy (NSABP B-51\/RTOG 1304). N Engl J Med. 2025;392:2113\u201324.","journal-title":"N Engl J Med"},{"key":"1895_CR13","doi-asserted-by":"publisher","first-page":"znae071","DOI":"10.1093\/bjs\/znae071","volume":"111","author":"SR de Wild","year":"2024","unstructured":"de Wild SR, Koppert LB, van Nijnatten TJA, Kooreman LFS, Vrancken Peeters MJTFD, Smidt ML, et al. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement. Br J Surg. 2024;111:znae071.","journal-title":"Br J Surg"},{"key":"1895_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","volume":"157","author":"JM Simons","year":"2022","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, et al. Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg. 2022;157:991\u20139.","journal-title":"JAMA Surg"},{"key":"1895_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ejso.2022.12.019","volume":"49","author":"PA Barry","year":"2023","unstructured":"Barry PA, Harborough K, Sinnett V, Heeney A, St John ER, Gagliardi T, et al. Clinical utility of axillary nodal markers in breast cancer. Eur J Surg Oncol. 2023;49:709\u201315.","journal-title":"Eur J Surg Oncol"},{"key":"1895_CR16","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1245\/s10434-020-08902-y","volume":"27","author":"A Laws","year":"2020","unstructured":"Laws A, Dillon K, Kelly BN, Kantor O, Hughes KS, Gadd MA, et al. Node-positive patients treated with neoadjuvant chemotherapy can be spared axillary lymph node dissection with wireless non-radioactive localizers. Ann Surg Oncol. 2020;27:4819\u201327.","journal-title":"Ann Surg Oncol"},{"key":"1895_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clinimag.2022.07.007","volume":"90","author":"RJ Weinfurtner","year":"2022","unstructured":"Weinfurtner RJ, Leon A, Calvert A, Lee MC. Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection. Clin Imaging. 2022;90:19\u201325.","journal-title":"Clin Imaging"},{"key":"1895_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10549-022-06588-2","volume":"193","author":"J de Boniface","year":"2022","unstructured":"de Boniface J, Frisell J, Kuhn T, Wiklander-Brakenhielm I, Dembrower K, Nyman P, et al. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy. Breast Cancer Res Treat. 2022;193:589\u201395.","journal-title":"Breast Cancer Res Treat"},{"key":"1895_CR19","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","volume":"276","author":"S Kuemmel","year":"2022","unstructured":"Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, et al. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients. Ann Surg. 2022;276:e553\u201362.","journal-title":"Ann Surg"},{"key":"1895_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","volume":"44","author":"S Hartmann","year":"2018","unstructured":"Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol. 2018;44:1307\u201311.","journal-title":"Eur J Surg Oncol"},{"key":"1895_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12282-022-01349-x","volume":"29","author":"CS Pinto","year":"2022","unstructured":"Pinto CS, Peleteiro B, Pinto CA, Os\u00f3rio F, Costa S, Magalh\u00e3es A, et al. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients. Breast Cancer. 2022;29:709\u201319.","journal-title":"Breast Cancer"},{"key":"1895_CR22","doi-asserted-by":"publisher","first-page":"106938","DOI":"10.1016\/j.ejso.2023.05.013","volume":"49","author":"C Siso","year":"2023","unstructured":"Siso C, Esgueva A, Rivero J, Morales C, Miranda I, Peg V, et al. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment. Eur J Surg Oncol. 2023;49:106938.","journal-title":"Eur J Surg Oncol"},{"key":"1895_CR23","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cam4.2848","volume":"9","author":"GH Lim","year":"2020","unstructured":"Lim GH, Teo SY, Gudi M, Ng RP, Pang J, Tan YS, et al. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: skin mark clipped axillary nodes removal technique (SMART trial). Cancer Med. 2020;9:1978\u201385.","journal-title":"Cancer Med"},{"key":"1895_CR24","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/diagnostics12102424","volume":"12","author":"KE Kim","year":"2022","unstructured":"Kim KE, Ko EY, Han BK, Ko ES, Choi JS, Kim H, et al. Comparison of the ultrasound visibility of tissue markers in metastatic lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Diagnostics (Basel). 2022;12:2424.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1895_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3233\/BD-210078","volume":"41","author":"SYS Lee","year":"2022","unstructured":"Lee SYS, Win T, Lee YS, Teo SY. Sonographic visibility of the UltraCor\u2122 Twirl\u2122 tissue marker. Breast Dis. 2022;41(1):535\u201343. https:\/\/doi.org\/10.3233\/BD-210078.","journal-title":"Breast Dis"},{"key":"1895_CR26","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.29011\/2575-9760.001595","volume":"7","author":"N Sakamoto","year":"2022","unstructured":"Sakamoto N, Fukuma E, Kurozumi M, Machida Y, Nashimoto M, Matsumoto K, et al. Axillary evaluation with targeted axillary dissection using ultrasound-visible clips after neoadjuvant chemotherapy for patients with node-positive breast cancer. J Surg. 2022;7:1595. https:\/\/doi.org\/10.29011\/2575-9760.001595.","journal-title":"J Surg"},{"key":"1895_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"1895_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10549-020-05840-x","volume":"184","author":"LH Portnow","year":"2020","unstructured":"Portnow LH, Ellie Kwak E, Senapati GM, Kwait DC, Denison CM, Giess CS, et al. Ultrasound visibility of select breast biopsy markers for targeted axillary node localization following neoadjuvant treatment: simulation using animal tissue models. Breast Cancer Res Treat. 2020;184:185\u201392.","journal-title":"Breast Cancer Res Treat"},{"key":"1895_CR29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/cancers13071565","volume":"13","author":"M Banys-Paluchowski","year":"2021","unstructured":"Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, AXSANA Study Group, et al. Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study. Cancers (Basel). 2021;13:1565.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1895_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-023-01510-0","volume":"31","author":"T Sakai","year":"2024","unstructured":"Sakai T, Kutomi G, Shien T, Asaga S, Aruga T, Ishitobi M, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition. Breast Cancer. 2024;31(1):1\u20137.","journal-title":"Breast Cancer"},{"issue":"1052","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"20150143","DOI":"10.1259\/bjr.20150143","volume":"88","author":"S You","year":"2015","unstructured":"You S, Kang DK, Jung YS, An YS, Jeon GS, Kim TH. Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and 18F-FDG PET\/CT. Br J Radiol. 2015;88(1052):20150143.","journal-title":"Br J Radiol"},{"issue":"1","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190014","volume":"293","author":"R Kim","year":"2019","unstructured":"Kim R, Chang JM, Lee HB, Lee SH, Kim SY, Kim ES, et al. Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer. Radiology. 2019;293(1):49\u201357.","journal-title":"Radiology"},{"key":"1895_CR33","doi-asserted-by":"publisher","first-page":"115607","DOI":"10.1016\/j.ejca.2025.115607","volume":"226","author":"R Di Micco","year":"2025","unstructured":"Di Micco R, Hartmann S, Banys-Paluchowski M, de Boniface J, Schmidt E, Ditsch N, et al. Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients: results from the prospective AXSANA registry trial. Eur J Cancer. 2025;226:115607.","journal-title":"Eur J Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01895-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01895-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01895-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:59:11Z","timestamp":1787839151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01895-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01895-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8962245\/v1","asserted-by":"object"}]},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective study was approved by the Institutional Review Board of our hospital (IRB No. 24\u2013158).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was obtained using an opt-out method in accordance with institutional policy.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}